Advanced epithelial ovarian cancer: 1998 consensus statements.
about
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinomaRole of primary surgery in advanced ovarian cancerPerformance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma.A new therapeutical approach: topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum.Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.Major clinical research advances in gynecologic cancer in 2010Biological variation and reference change values of CA 19-9, CEA, AFP in serum of healthy individuals.Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic reviewTXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer.Management of recurrent epithelial ovarian carcinoma.Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?Palliative Surgical Approach in Advanced Nonresponsive Mucinous Ovarian Cancer: A Rare Case Report.Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer.TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.The rationale for mTOR inhibition in epithelial ovarian cancer.The role of surgery in the management of epithelial ovarian cancer.Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer.
P2860
Q24791107-85660D2C-D08F-4637-998A-37936BD593F8Q24803931-793B2139-CDCF-442A-9180-27AC0A7E399DQ33341835-039FFA0B-0B53-4100-BFF4-36C9D83CF7EDQ33348813-CCA1F3DF-0DA5-4DEC-80A3-F3F6D481B268Q33710438-CE652474-12B5-40ED-8D24-00D0006AF10CQ34517694-D7392BC4-D8F8-4E1C-A781-27EA0B2C5539Q34699940-4301FFE2-24B0-494B-A367-93902D487314Q35583734-4CD65118-489D-4D1B-AD93-72D458AFFB3FQ35852757-3B9BE762-FAE5-49E7-96E3-A516BFDBC43EQ36089005-EA4E04AA-4D0D-43F5-B169-598322A2E9C2Q36200382-50758D85-E564-487B-A47E-6735783A1C2AQ36671058-0717B199-5CCD-4544-9088-66563BF40F75Q36694465-4AB25FA6-3592-46CE-BB3D-F30BFF0F9D0BQ36831864-6E627966-E4FE-4447-8C29-CA96D0CA7FACQ37352629-8C3C4FEA-C136-488C-A6DE-C315365519E3Q37480340-BFF45F55-549A-4CCB-94F4-0DDEF5FBCBADQ37627253-0F60248E-BE6D-4719-B44F-805B1BCFA575Q37832930-01015313-6A05-4263-9F26-3175F260D312Q40553784-F8A36885-774A-40FD-BCC6-FD66E8D97437Q42566962-F62D144E-D1C3-4825-95BD-6F3A2C18DCC0Q43910355-841032AE-F9BB-4D12-B115-EF411AFB509A
P2860
Advanced epithelial ovarian cancer: 1998 consensus statements.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Advanced epithelial ovarian cancer: 1998 consensus statements.
@ast
Advanced epithelial ovarian cancer: 1998 consensus statements.
@en
type
label
Advanced epithelial ovarian cancer: 1998 consensus statements.
@ast
Advanced epithelial ovarian cancer: 1998 consensus statements.
@en
prefLabel
Advanced epithelial ovarian cancer: 1998 consensus statements.
@ast
Advanced epithelial ovarian cancer: 1998 consensus statements.
@en
P2093
P356
P1433
P1476
Advanced epithelial ovarian cancer: 1998 consensus statements.
@en
P2093
E A Eisenhauer
G J Rustin
J Carmichael
P356
10.1023/A:1008323922057
P478
10 Suppl 1
P577
1999-01-01T00:00:00Z